GlaxoSmithKline PLC  

(Public, ETR:GS7)   Watch this stock  
Find more results for GS7
21.28
-0.16 (-0.72%)
Feb 27 - Close
ETR data delayed by 15 mins - Disclaimer
Currency in EUR
Range 21.17 - 21.42
52 week 16.20 - 21.42
Open 21.40
Vol / Avg. 26,180.00/53,152.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares 1.00
Beta     -
Inst. own     -
May 7, 2015
GlaxoSmithKline PLC Annual Shareholders Meeting (Estimated) - 3:30PM GMT+2 - Add to calendar
May 7, 2015
GlaxoSmithKline PLC Annual Shareholders Meeting Add to calendar
Apr 29, 2015
Q1 2015 GlaxoSmithKline PLC Earnings Release - 9:00AM GMT+2 - Add to calendar
Feb 4, 2015
Q4 2014 GlaxoSmithKline PLC Earnings Call
Feb 4, 2015
Q4 2014 GlaxoSmithKline PLC Earnings Release
Jan 14, 2015
GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Q&A)
Jan 14, 2015
GlaxoSmithKline PLC at JPMorgan Healthcare Conference
Dec 18, 2014
GlaxoSmithKline PLC Ordinary Shareholders Meeting
Dec 3, 2014
GlaxoSmithKline PLC at Berenberg European Conference
  

Address

980 Great West Road
BRENTFORD, TW8 9GS
United Kingdom - Map
+44-20-80475000 (Phone)
+44-20-80477807 (Fax)

Website links

External links

Description

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK�s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

Officers and directors

Andrew Philip Witty Chief Executive Officer, Executive Director
Age: 49
Simon Dingemans Chief Financial Officer, Executive Director
Age: 50
Moncef Slaoui Chairman, Executive Director
Age: 54
Deirdre P. Connelly President - North American Pharmaceuticals
Age: 53
Roger Connor President - Global Manufacturing & Supply
Shah Abbas Hussain President - Europe, Japan & EMAP
Age: 49
Patrick Vallance President - Pharmaceuticals R&D
Emma Walmsley President - Consumer Healthcare Worldwide
Daniel Troy Senior Vice President, General Counsel
Claire Thomas Senior Vice President - Human Resources